Showing results (1461-1470 of 4,704) with videos related to
Sort By:
Pageof 471
IEEE Transactions on Cybernetics|May 13, 2026
Multiscale Spatial Frequency-Aware Transformer and Saturation Analysis for Universal Deepfake DetectionKaiwen Xu, Xiyuan Hu, Chen Chen, et al.Geriatrics & Gerontology International|March 8, 2026
Joint Assessment of Sarcopenia and Lipid Parameters on Cardiovascular Diseases in Middle-Aged and Older Adults in China With Different Glucose Metabolism StatusWeichen Luo, Yang Xu, Zaixiao Tao, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2014
Sequence-specific alterations of epitope production by HIV protease inhibitorsGeorgio Kourjian, Yang Xu, Ijah Mondesire-Crump, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 15, 2014
Anti-tumor activities of matrine and oxymatrine: literature reviewYan Liu, Yang Xu, Weidan Ji, et al.Environmental Research|March 18, 2019
Effects of citrate ester plasticizers and bis (2-ethylhexyl) phthalate in the OECD 28-day repeated-dose toxicity test (OECD TG 407)Yang Xu, Seung Hyun Park, Kyung Noh Yoon, et al.Connective Tissue Research|March 23, 2019
Lithium chloride attenuates suppressed differentiation induced by mechanical strain in cementoblastsMengke Ge, Chenchen Zhou, Huang Li, et al.Oncotarget|April 8, 2017
αMSH prevents ROS-induced apoptosis by inhibiting Foxo1/mTORC2 in mice adipose tissueWeina Cao, Meihang Li, Tianjiao Wu, et al.Chinese Medical Journal|February 27, 2023
Challenges and optimal strategies of CAR T therapy for hematological malignanciesYajing Zhang, Yang Xu, Xiuyong Dang, et al.Discover Oncology|August 26, 2025
PCK1 and ALDH1A1 are identified as biomarkers for inherent drug resistance in hepatocellular carcinomaWei Chen, Cheng Zhou, Gao Liu, et al.Journal of Gastrointestinal Oncology|March 14, 2023
Establishment and validation of a predictive model of recurrence in primary hepatocellular carcinoma after resectionYang Xu, Huimin Han, Wei Cao, et al.Pageof 471